Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples